Search clinical trials for: Dexrazoxane (DZR)
Total 435 results
-
PD Dr. Andrew ChanUnknown
-
Fudan UniversityTerminated
-
Guru P. SonpavdeQED Therapeutics, Inc.WithdrawnBladder Cancer | Bladder Transitional Cell Carcinoma | Fibroblast Growth Factor Receptor
-
Jilin UniversityUnknownAntineoplastic Combined Chemotherapy ProtocolsChina
-
University of North Carolina, Chapel HillNational Heart, Lung, and Blood Institute (NHLBI)Terminated
-
Tehran University of Medical SciencesUnknownPrimary Acquired NasolacrimalIran, Islamic Republic of
-
Dicerna Pharmaceuticals, Inc.ParexelCompleted
-
Dicerna Pharmaceuticals, Inc.CompletedHepatitis B, ChronicKorea, Republic of, New Zealand, Australia, Thailand, Hong Kong
-
Kezar Life Sciences, Inc.Recruiting
-
Azura OphthalmicsSyneos Health; Cliantha ResearchCompletedDry Eye | Meibomian Gland DysfunctionCanada, Australia, New Zealand
-
DurectCTI Clinical Trial and Consulting ServicesCompletedAlcoholic HepatitisUnited States
-
Kezar Life Sciences, Inc.CompletedDermatomyositis | PolymyositisUnited States
-
Azura OphthalmicsORA, Inc.Not yet recruitingDry Eye DiseaseUnited States
-
Fractyl Health Inc.CompletedDiabetes Mellitus, Type 2 | Noninsulin-Dependent Diabetes MellitusUnited Kingdom, Belgium, Brazil, Italy, Netherlands
-
University Rehabilitation Institute, Republic of...CompletedAmputation; Traumatic, Leg, Lower, Between Knee and AnkleSlovenia
-
Kezar Life Sciences, Inc.WithdrawnImmune Thrombocytopenia | Autoimmune Hemolytic AnemiaPoland, United States, Australia, Italy, Russian Federation
-
Azura OphthalmicsAvaniaCompletedMeibomian Gland DysfunctionAustralia, New Zealand
-
Dicerna Pharmaceuticals, Inc., a Novo Nordisk companyCompleted
-
Azura OphthalmicsThe University of New South WalesCompletedMeibomian Gland Dysfunction (MGD) | Contact Lens Discomfort (CLD)Australia
-
City of Hope Medical CenterNational Cancer Institute (NCI)CompletedUnspecified Adult Solid Tumor, Protocol Specific
-
University of AdelaideUniversity of Sydney; Salk Institute for Biological StudiesRecruiting
-
Dicerna Pharmaceuticals, Inc., a Novo Nordisk companyRecruitingPrimary Hyperoxaluria Type 3 | Primary Hyperoxaluria Type 2 | Primary Hyperoxaluria Type 1 | Primary HyperoxaluriaUnited States, Canada, Lebanon, Turkey, United Kingdom, Germany, Italy, Japan, Poland, Spain, United Arab Emirates
-
Fractyl Health Inc.Enrolling by invitationDiabetes Mellitus, Type 2Germany
-
Assiut UniversityNot yet recruiting
-
Gamaleya Research Institute of Epidemiology and...MSD Pharmaceuticals LLCNot yet recruiting
-
Charles Drew University of Medicine and ScienceAmerican Diabetes AssociationCompleted
-
University of RochesterNational Cancer Institute (NCI); National Institute on Aging (NIA)RecruitingCancer, Advanced | Cognitive Impairment, MildUnited States
-
Lawson Health Research InstituteCanadian Institutes of Health Research (CIHR)RecruitingPTSD | Post-traumatic Stress DisorderCanada
-
L. Michael BruntUniversity of Oregon; Northwestern University; Duke University; University of WashingtonCompletedEsophageal AchalasiaUnited States
-
Sol-Gel Technologies, Ltd.Completed
-
Wang SiqiChina-Japan Friendship HospitalNot yet recruiting
-
DurectTerminatedPrimary Sclerosing CholangitisUnited States
-
Erasme University HospitalFractyl Laboratories, Inc.Completed
-
Dicerna Pharmaceuticals, Inc.TerminatedHepatocellular CarcinomaKorea, Republic of, United States, Singapore
-
Dicerna Pharmaceuticals, Inc.TerminatedMultiple Myeloma | PNET | Solid Tumors | Non-Hodgkins Lymphoma | NHL | Pancreatic Neuroendocrine TumorsUnited States
-
MaineHealthRobert Wood Johnson FoundationCompleted
-
Dicerna Pharmaceuticals, Inc., a Novo Nordisk companyRecruitingEnd Stage Renal Disease | Primary Hyperoxaluria Type 2 | Primary Hyperoxaluria Type 1Germany, Spain, United States, United Kingdom, Italy, United Arab Emirates, Lebanon, Morocco, France, Romania
-
Academisch Medisch Centrum - Universiteit van Amsterdam...Fractyl Health, Inc.Not yet recruiting
-
University of Colorado, DenverNational Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)RecruitingOverweight and ObesityUnited States
-
National Taiwan University HospitalCompleted
-
UCB Biopharma SRLActive, not recruitingSystemic Lupus ErythematosusUnited States, Argentina, Australia, Austria, Belgium, Bulgaria, Canada, Chile, Colombia, Czechia, Denmark, France, Germany, Greece, Hungary, Italy, Korea, Republic of, Mexico, Peru, Philippines, Poland, Romania, Serbia, Spain, Taiwan
-
UCB Biopharma SRLEnrolling by invitationSystemic Lupus ErythematosusUnited States, Argentina, Belgium, Bulgaria, Canada, Chile, Czechia, Germany, Greece, Hungary, Mexico, Poland, Romania, Serbia, Spain, Taiwan, Colombia, Italy, Korea, Republic of, Peru, Philippines
-
Fractyl Health Inc.CompletedDiabetes Mellitus, Type 2 | Diabetes MellitusUnited Kingdom, Belgium, Netherlands, Chile, Italy
-
DurectCTI Clinical Trial and Consulting ServicesCompletedAlcoholic HepatitisUnited States, Australia, United Kingdom, France, Belgium, Austria
-
Children's Oncology GroupNational Cancer Institute (NCI); Children's Cancer GroupCompletedLymphoma | Cardiac ToxicityUnited States, Australia, Canada
-
Yonsei UniversityBoston Scientific Corporation; Severance HospitalCompletedCoronary Artery Disease | Coronary StenosisKorea, Republic of
-
BiogenCompleted
-
Duke UniversityUniversity of Washington; University of Toronto; Virginia Commonwealth UniversityNot yet recruitingCardiac Arrest | Sudden Cardiac Arrest
-
Kezar Life Sciences, Inc.CompletedDermatomyositis | PolymyositisUnited States, Czechia, Germany